Fibrinogen, platelet and factor XIII supplementation in cardiac surgery

The aims were to determine (1) whether thromboelas- tometry analyses can be accelerated, (2) whether routine use of intraoperative thromboe- lastometry reduces

(1) To investigate activity of individual coagulation factors in cardiac surgery with cardiopulmonary bypass (CPB) in relation to hemodilution and bleeding volume

II) Radulovic V, Hyllner M, Ternström L, Karlsson M, Bylock A, Hansson KM, Baghaei F, Jeppsson A. Heparin and protamine titration does not improve thrombin generation capacity after

The general aim of this work was to investigate the effect of platelet inhibition on bleeding complications and transfusion requirements in cardiac surgery patients, to examine

BACKGROUND AND OBJECTIVE: Dual antiplatelet therapy (DAPT) with acetylsalicylic acid and a P2Y 12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces thrombotic events

Renal effects of dextran-based versus crystalloid-based priming solution in cardiopulmonary bypass: A randomized controlled study in adult cardiac surgery

Prophylactic fibrinogen infusion in cardiac surgery patients: effects on biomarkers of coagulation, fibrinolysis and platelet function.. Accepted for publication in Clinical

II: Postoperative bleeding volume correlated univariately with preoperative fibrinogen concentration (r = -0.53, p<0.001). Fibrinogen was an independent predictor of